KR860002464A - 프롤린유도체의 제조방법 - Google Patents

프롤린유도체의 제조방법 Download PDF

Info

Publication number
KR860002464A
KR860002464A KR1019850006633A KR850006633A KR860002464A KR 860002464 A KR860002464 A KR 860002464A KR 1019850006633 A KR1019850006633 A KR 1019850006633A KR 850006633 A KR850006633 A KR 850006633A KR 860002464 A KR860002464 A KR 860002464A
Authority
KR
South Korea
Prior art keywords
alk
product
pharmaceutically acceptable
phenylpropyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019850006633A
Other languages
English (en)
Korean (ko)
Inventor
에스. 네이스 에드워드 (외 5)
Original Assignee
원본미기재
유 에스 브이 파마슈티칼 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/649,797 external-priority patent/US4746676A/en
Priority claimed from US06/752,695 external-priority patent/US4749698A/en
Application filed by 원본미기재, 유 에스 브이 파마슈티칼 코포레이션 filed Critical 원본미기재
Publication of KR860002464A publication Critical patent/KR860002464A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019850006633A 1984-09-12 1985-09-11 프롤린유도체의 제조방법 Ceased KR860002464A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/649,797 US4746676A (en) 1984-09-12 1984-09-12 Carboxyalkyl dipeptide compounds
US649..797 1984-09-12
US06/752,695 US4749698A (en) 1985-07-08 1985-07-08 Antihypertensive derivatives
US752.695 1985-07-08

Publications (1)

Publication Number Publication Date
KR860002464A true KR860002464A (ko) 1986-04-26

Family

ID=27095707

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850006633A Ceased KR860002464A (ko) 1984-09-12 1985-09-11 프롤린유도체의 제조방법

Country Status (13)

Country Link
EP (1) EP0175266B1 (enExample)
KR (1) KR860002464A (enExample)
AT (1) ATE135711T1 (enExample)
AU (1) AU578489B2 (enExample)
CA (1) CA1288893C (enExample)
DE (1) DE3588094T2 (enExample)
DK (1) DK412985A (enExample)
ES (1) ES8609364A1 (enExample)
FI (1) FI89716C (enExample)
IL (1) IL76345A (enExample)
IN (1) IN164615B (enExample)
NO (1) NO169442C (enExample)
NZ (1) NZ213432A (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
JPH10501818A (ja) * 1994-06-16 1998-02-17 スミスクライン・ビーチャム・コーポレイション 鋳型指向性環化
CA2388468C (en) 1999-10-14 2011-01-25 Curis, Inc. Mediators of hedgehog signalling pathways, compositions and uses related thereto
ES2346399T3 (es) 2000-09-21 2010-10-15 Abb Schweiz Ag Configuracion de un sistema de control de una instalacion electrica.
SG170767A1 (en) * 2005-12-23 2011-05-30 Zealand Pharma As Modified lysine-mimetic compounds
EP2468724B1 (en) * 2006-12-21 2015-11-18 Zealand Pharma A/S Synthesis of pyrrolidine compounds
WO2018202865A1 (en) 2017-05-05 2018-11-08 Zealand Pharma A/S Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
GR75019B (enExample) * 1980-09-17 1984-07-12 Univ Miami
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
FR2501399B1 (fr) * 1981-03-03 1987-06-19 France Etat Dispositif d'affichage de messages graphiques transmis par des systemes de videotex
EP0080822A1 (en) * 1981-11-27 1983-06-08 Beecham Group Plc Anti-hypertensive prolinol-based peptides
EP0088350B1 (en) * 1982-03-08 1985-02-20 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
CA1258853A (en) * 1982-04-30 1989-08-29 Rudiger D. Haugwitz Substituted 4-phenoxy prolines
AU1643283A (en) * 1982-07-19 1984-01-26 E.R. Squibb & Sons, Inc. Substituted peptides
US4623729A (en) * 1982-07-22 1986-11-18 E. R. Squibb & Sons, Inc. Acylalkylaminocarbonyl substituted amino and imino acid compounds
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DK156484A (da) * 1983-03-16 1984-09-17 Usv Pharma Corp Aminosyrederivater
ZA843899B (en) * 1983-05-23 1984-12-24 Usv Pharma Corp Compounds for treating hypertension

Also Published As

Publication number Publication date
FI89716C (fi) 1993-11-10
AU578489B2 (en) 1988-10-27
IN164615B (enExample) 1989-04-22
EP0175266A2 (en) 1986-03-26
FI89716B (fi) 1993-07-30
DK412985D0 (da) 1985-09-11
CA1288893C (en) 1991-09-10
NO169442B (no) 1992-03-16
NO169442C (no) 1992-06-24
ATE135711T1 (de) 1996-04-15
NO853551L (no) 1986-03-13
DE3588094D1 (de) 1996-04-25
EP0175266A3 (en) 1988-08-03
AU4733185A (en) 1986-03-20
EP0175266B1 (en) 1996-03-20
NZ213432A (en) 1988-11-29
FI853494L (fi) 1986-03-13
ES8609364A1 (es) 1986-07-16
IL76345A0 (en) 1986-01-31
ES546866A0 (es) 1986-07-16
DE3588094T2 (de) 1996-08-22
FI853494A0 (fi) 1985-09-12
IL76345A (en) 1988-12-30
DK412985A (da) 1986-03-13

Similar Documents

Publication Publication Date Title
KR910000613A (ko) 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조방법 및 이를 포함하는 조성물
KR840001952A (ko) N-(4-(3-아미노프로필) 아미노부틸)-2-(ω)-과니디노-지방산-아미도)-2-치환된-에탄아미드 이들의 염 및 이들의 제조방법
KR960014094A (ko) 아스파라긴산 프로테아제 기질 동배체의 항바이러스성 에테르
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
RU2008129204A (ru) Применение ингибитора ibat для лечения или профилактики запора
DK116480A (da) Fremgangsmaade til fremstilling af substituerede chromoner
DE69528437D1 (de) Substituierte azaindolylidenderivate und verfahren zu ihrer herstellung
KR860002464A (ko) 프롤린유도체의 제조방법
RU2009124590A (ru) Комбинация ингибиторов iap и flt3
CA2140598A1 (en) Prolineamide derivatives
RU92016217A (ru) Двойные ингибиторы no синтазы и циклооксигеназы, способ их получения и фармацевтическая композиция на их основе
KR860004081A (ko) 폴리펩티드의 제조방법
ATE16805T1 (de) Trifluoromethylphenyltetrahydropyridine mit appetithemmender wirkung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR900004658A (ko) 이치환 벤질아민, 그의 제조방법, 약제로서의 그의 용도 및 그의 합성 약제
FI895921A0 (fi) Enzymhaemmande aminosyraderivat, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
RU2008122712A (ru) Комбинация органических соединений
DE3561819D1 (en) Derivatives of methylenediphosphonic acid, process for their preparation and antirheumatic pharmaceutical compositions containing them
DK0630231T3 (da) Liposomer med negativ overskudsladning
KR840007571A (ko) 락탐 펩티드의 제조방법
RU2214404C2 (ru) Тиазольные производные, способ получения и фармацевтическая композиция на их основе
ATE271551T1 (de) Verfahren zur herstellung von n-(1-(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin-n- carboxyanhydrid
KR960703119A (ko) 합성적 용도로 사용하기 위한 신규한 중간체 및 아미노피페라진 유도체를 제조하는 방법(Novel intermediate for synthetic use and process for producing amino-piperazine derivative)
Merchán et al. Determination of the absolute configuration of α-amino-2-alkylthiazoles by circular dichroism
RU2220954C2 (ru) ЗАМЕЩЕННЫЕ β-АЛАНИНЫ
RU2201420C2 (ru) Нитрилы дипептидов

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850911

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19870928

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19850911

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19900412

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19900625

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19900412

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I